S
Sophie Ohlsson
Researcher at Lund University
Publications - 37
Citations - 1899
Sophie Ohlsson is an academic researcher from Lund University. The author has contributed to research in topics: Anti-neutrophil cytoplasmic antibody & Vasculitis. The author has an hindex of 15, co-authored 34 publications receiving 1544 citations. Previous affiliations of Sophie Ohlsson include University of Copenhagen & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Paul A. Lyons,Tim F. Rayner,Sapna Trivedi,Julia U Holle,Richard A. Watts,David Jayne,Bo Baslund,Paul Brenchley,Annette Bruchfeld,Afzal N. Chaudhry,Jan Willem Cohen Tervaert,Panos Deloukas,Conleth Feighery,Wolfgang L. Gross,Loïc Guillevin,Iva Gunnarsson,Lorraine Harper,Zdenka Hruskova,Mark A. Little,Davide Martorana,Thomas Neumann,Sophie Ohlsson,Sophie Ohlsson,Sandosh Padmanabhan,Charles D. Pusey,Alan D. Salama,Alan D. Salama,Jan-Stephan F. Sanders,Caroline O. S. Savage,Mårten Segelmark,Mårten Segelmark,Mårten Segelmark,Coen A. Stegeman,Vladimir Tesar,Augusto Vaglio,Stefan Wieczorek,Benjamin Wilde,Jochen Zwerina,Jochen Zwerina,Andrew J. Rees,David Clayton,Kenneth G. C. Smith +41 more
TL;DR: This study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyang iitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature ofproteinase 3 ANCA -associated vasulitis.
Journal ArticleDOI
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
Stephen P. McAdoo,Anisha Tanna,Zdenka Hruskova,Lisa Holm,Maria Weiner,Nishkantha Arulkumaran,Amy Kang,Veronika Satrapova,Jeremy Levy,Sophie Ohlsson,Vladimir Tesar,Mårten Segelmark,Charles D. Pusey +12 more
TL;DR: Double-positive patients have a truly hybrid disease phenotype, requiring aggressive early treatment for anti-GBM disease, and careful long-term follow-up and consideration for maintenance immunosuppression for AAV.
Journal ArticleDOI
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.
Paul A. Lyons,James E. Peters,Federico Alberici,Federico Alberici,James Liley,James Liley,Richard M.R. Coulson,William J. Astle,William J. Astle,William J. Astle,Chiara Baldini,Francesco Bonatti,Maria C. Cid,Heather Elding,Heather Elding,Giacomo Emmi,Jörg T. Epplen,Loïc Guillevin,David Jayne,Tao Jiang,Iva Gunnarsson,Peter Lamprecht,Stephen Leslie,Mark A. Little,Davide Martorana,Frank Moosig,Thomas Neumann,Sophie Ohlsson,Stefanie Quickert,Giuseppe A. Ramirez,Barbara Rewerska,Georg Schett,Renato Alberto Sinico,Wojciech Szczeklik,Vladimir Tesar,Damjan Vukcevic,Benjamin Terrier,Richard A. Watts,Richard A. Watts,Augusto Vaglio,Julia U Holle,Chris Wallace,Chris Wallace,Kenneth G. C. Smith +43 more
TL;DR: A genome-wide association study of EGPA is described that reveals clinical and genetic differences between subgroups stratified by autoantibody status (ANCA), and four candidate genes are targets of therapies in development, supporting their exploration in EGPA.
Journal ArticleDOI
Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP
Sara Rørvig,Christian Honoré,Lars-Inge Larsson,Sophie Ohlsson,Corinna Cavan Pedersen,Lars C. Jacobsen,Jack B. Cowland,Peter Garred,Niels Borregaard +8 more
TL;DR: It is shown that neutrophils are a major source of ficolin‐1, which can be readily exocytosed by stimulation, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry.
Journal ArticleDOI
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
TL;DR: It is found that levels of proteinase 3 (PR3), one of the main ANCA antigens, are increased in patients with active disease, regardless of ANCA specificity, and this was not due to decreased renal function, ongoing inflammation or neutrophil activation.